Pomegranate polyphenolics suppressed azoxymethane-induced colorectal aberrant crypt foci and inflammation: Possible role of miR-126/VCAM-1 and miR-126/PI3K/ AKT/mTOR

Carcinogenesis

Volumn 34, Issue 12, 2013, Pages 2814-2822

  Banerjee, Nivedita ^a,b   Kim, Hyemee ^a   Talcott, Stephen ^a   Mertens Talcott, Susanne ^a,b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTAGOMIR; ANTHOCYANIN; AZOXYMETHANE; CYCLOOXYGENASE 2; ELLAGITANNIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MICRORNA 126; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; POLYPHENOL DERIVATIVE; POMEGRANATE EXTRACT; PROTEIN KINASE B; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ABERRANT CRYPT FOCUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; AZOXYMETHANE INDUCED COLORECTAL ABERRANT CRYPT FOCI; BODY WEIGHT; CANCER CELL CULTURE; CANCER MODEL; CELL PROLIFERATION; CELL STRAIN HT29; COLON CARCINOGENESIS; COLON CARCINOMA; CONTROLLED STUDY; DRUG CYTOTOXICITY; FOOD INTAKE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MUCOSA CELL; NONHUMAN; PHOSPHORYLATION; POMEGRANATE; POMEGRANATE JUICE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

ABERRANT CRYPT FOCI; ANIMALS; ANTICARCINOGENIC AGENTS; AZOXYMETHANE; BEVERAGES; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; HT29 CELLS; HUMANS; INFLAMMATION; MALE; MICRORNAS; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHATIDYLINOSITOL 3-KINASE; POLYPHENOLS; PROTO-ONCOGENE PROTEINS C-AKT; PUNICACEAE; RATS; RATS, SPRAGUE-DAWLEY; TOR SERINE-THREONINE KINASES; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84888988840     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt295     Document Type: Article

References (47)

1. Siegel,R. et al. (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. Cancer J. Clin., 61, 212-236.
2. Chen,J. et al. (2009) The signal pathways in azoxymethane-induced colon cancer and preventive implications. Cancer Biol. Ther., 8, 1313-1317.
3. Vargas,P.A. et al. (1992) Primary prevention of colorectal cancer through dietary modification. Cancer, 70 (suppl. 5), 1229-1235.
4. Chiou,Y.S. et al. (2011) Pterostilbene is more potent than resveratrol in preventing azoxymethane (AOM)-induced colon tumorigenesis via activation of the NF-E2-related factor 2 (Nrf2)-mediated antioxidant signaling pathway. J. Agric. Food Chem., 59, 2725-2733.
5. Paul,S. et al. (2010) Dietary intake of pterostilbene, a constituent of blueberries, inhibits the beta-catenin/p65 downstream signaling pathway and colon carcinogenesis in rats. Carcinogenesis, 31, 1272-1278.
6. Xiao,H. et al. (2008) Green tea polyphenols inhibit colorectal aberrant crypt foci (ACF) formation and prevent oncogenic changes in dysplastic ACF in azoxymethane-treated F344 rats. Carcinogenesis, 29, 113-119.
7. Afaq,F. et al. (2005) Anthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in CD-1 mice. Int. J. Cancer, 113, 423-433.
8. Seeram,N.P. et al. (2005) In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J. Nutr. Biochem., 16, 360-367.
9. Malik,A. et al. (2005) Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc. Natl Acad. Sci. USA, 102, 14813-14818.
10. Banerjee,N. et al. (2012) Cytotoxicity of pomegranate polyphenolics in breast cancer cells in vitro and vivo: potential role of miRNA-27a and miRNA-155 in cell survival and inflammation. Breast Cancer Res. Treat., 136, 21-34.
11. Hora,J.J. et al. (2003) Chemopreventive effects of pomegranate seed oil on skin tumor development in CD1 mice. J. Med. Food, 6, 157-161.
12. Bishayee,A. et al. (2011) Pomegranate-mediated chemoprevention of experimental hepatocarcinogenesis involves Nrf2-regulated antioxidant mechanisms. Carcinogenesis, 32, 888-896.
13. Adams,L.S. et al. (2006) Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. J. Agric. Food Chem., 54, 980-985.
14. Adhami,V.M. et al. (2009) Cancer chemoprevention by pomegranate: laboratory and clinical evidence. Nutr. Cancer, 61, 811-815.
15. Kohno,H. et al. (2004) Pomegranate seed oil rich in conjugated linolenic acid suppresses chemically induced colon carcinogenesis in rats. Cancer Sci., 95, 481-486.
16. Jurenka,J.S. (2008) Therapeutic applications of pomegranate (Punica granatum L.): a review. Altern. Med. Rev., 13, 128-144.
17. Kawaii,S. et al. (2004) Differentiation-promoting activity of pomegranate (Punica granatum) fruit extracts in HL-60 human promyelocytic leukemia cells. J. Med. Food, 7, 13-18.
18. Alexiou,D. et al. (2001) Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: correlations with clinicopathological features, patient survival and tumour surgery. Eur. J. Cancer, 37, 2392-2397.
19. Saad,R.S. et al. (2004) Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer. Mod. Pathol., 17, 197-203.
20. Angel-Morales,G. et al. (2012) Red wine polyphenolics reduce the expression of inflammation markers in human colon-derived CCD-18Co myofibroblast cells: potential role of microRNA-126. Food Funct., 3, 745-752.
21. Khan,N. et al. (2007) Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice. Cancer Res., 67, 3475-3482.
22. Khan,N. et al. (2007) Pomegranate fruit extract inhibits prosurvival pathways in human A549 lung carcinoma cells and tumor growth in athymic nude mice. Carcinogenesis, 28, 163-173.
23. Surh,Y.J. et al. (2001) Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat. Res., 480-481, 243-268.
24. Guo,C. et al. (2008) The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes. Chromosomes Cancer, 47, 939-946.
25. Li,X.M. et al. (2011) Down-regulation of miR-126 expression in colorectal cancer and its clinical significance. Med. Oncol., 28, 1054-1057.
26. Harris,T.A. et al. (2008) MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc. Natl Acad. Sci. USA, 105, 1516-1521.
27. Mertens-Talcott,S.U. et al. (2013) Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: role of Sp transcription factors and microRNA-27a:ZBTB10. Mol. Carcinog., 52, 591-602.
28. Leonardi,T. et al. (2010) Apigenin and naringenin suppress colon carcinogenesis through the aberrant crypt stage in azoxymethane-treated rats. Exp. Biol. Med. (Maywood)., 235, 710-717.
29. Warren,C.A. et al. (2009) Quercetin may suppress rat aberrant crypt foci formation by suppressing inflammatory mediators that influence proliferation and apoptosis. J. Nutr., 139, 101-105.
30. Reagan-Shaw,S. et al. (2008) Dose translation from animal to human studies revisited. FASEB J., 22, 659-661.
31. Laaksonen,K.S. et al. (2013) Food and water intake, growth, and adiposity of Sprague-Dawley rats with diet board for 24 months. Lab Anim., 48, 153-161.
32. Bird,R.P. (1995) Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett., 93, 55-71.
33. Kasimsetty,S.G. et al. (2010) Colon cancer chemopreventive activities of pomegranate ellagitannins and urolithins. J. Agric. Food Chem., 58, 2180-2187.
34. Rettig,M.B. et al. (2008) Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-kappaB-dependent mechanism. Mol. Cancer Ther., 7, 2662-2671.
35. Luo,J. et al. (2003) Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell, 4, 257-262.
36. Leystra,A.A. et al. (2012) Mice expressing activated PI3K rapidly develop advanced colon cancer. Cancer Res., 72, 2931-2936.
37. Alrawi,S.J. et al. (2006) Aberrant crypt foci. Anticancer Res., 26(1A), 107-119.
38. Adhami,V.M. et al. (2012) Oral infusion of pomegranate fruit extract inhibits prostate carcinogenesis in the TRAMP model. Carcinogenesis, 33, 644-651.
39. Afaq,F. et al. (2005) Pomegranate fruit extract modulates UV-B-mediated phosphorylation of mitogen-activated protein kinases and activation of nuclear factor kappa B in normal human epidermal keratinocytes paragraph sign. Photochem. Photobiol., 81, 38-45.
40. Maurer,C.A. et al. (1998) Over-expression of ICAM-1, VCAM-1 and ELAM-1 might influence tumor progression in colorectal cancer. Int. J. Cancer, 79, 76-81.
41. Roy,H.K. et al. (2007) Inducible nitric oxide synthase (iNOS) mediates the early increase of blood supply (EIBS) in colon carcinogenesis. FEBS Lett., 581, 3857-3862.
42. Vanamala,J. et al. (2006) Suppression of colon carcinogenesis by bioactive compounds in grapefruit. Carcinogenesis, 27, 1257-1265.
43. Tsujii,M. et al. (1998) Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93, 705-716.
44. Choi,E.M. et al. (2005) COX-2 inhibits anoikis by activation of the PI-3K/Akt pathway in human bladder cancer cells. Exp. Mol. Med., 37, 199-203.
45. Poudyal,H. et al. (2010) Comparison of purple carrot juice and ß-carotene in a high-carbohydrate, high-fat diet-fed rat model of the metabolic syndrome. Br. J. Nutr., 104, 1322-1332.
46. Prior,R.L. et al. (2010) Purified blueberry anthocyanins and blueberry juice alter development of obesity in mice fed an obesogenic high-fat diet. J. Agric. Food Chem., 58, 3970-3976.
47. Sharman,M.J. et al. (2004) Weight loss leads to reductions in inflammatory biomarkers after a very-low-carbohydrate diet and a low-fat diet in overweight men. Clin. Sci. (Lond)., 107, 365-369.